3D Interaction,drug ligand name,target,Uniprot code,n_ca_T,n_ca_M,n_local_pairs,local_rmsd,local_coverage,vendor,smiles,clinical_phase,moa,database,cids,target chain id,chain name,Align Length,Binding_Affinity_kcal/mol
4C2V_YJA_O15906.pdb,YJA,4C2V,O15906,273,342,122,0.622,0.447,Selleck,CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)n[nH]3)ncnc2c1,Phase 2/Phase 3,Aurora kinase inhibitor,Uniprot,16007391,A,cAMP-dependent protein kinase [Plasmodium falciparum],264,-7.625
4C2V_YJA_Q6PLK2.pdb,YJA,4C2V,Q6PLK2,273,446,102,0.702,0.374,Selleck,CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)n[nH]3)ncnc2c1,Phase 2/Phase 3,Aurora kinase inhibitor,Uniprot,16007391,A,protein kinase B-like protein [Plasmodium falciparum],274,-8.264
